Stories

Ipsen’s Sandra Silvestri sat down with Dr. Laura Cristoferi, Professor Mark Swain, and Professor David Jones to explore the latest evidence on management of the rare, autoimmune disease, primary biliary cholangitis (PBC).

The first six months of 2025 have been exceptional for Ipsen. We’ve delivered strong growth across all three of our therapeutic areas — Rare Disease, Oncology, and Neuroscience — reflecting the strength of our strategy and the dedication of our teams. 

Joris is a thriving seven-and-a-half-year-old boy who has been on a journey requiring strength and hope from himself, and all those around him. At just four weeks old, Joris began exhibiting unusual symptoms; vomiting, changes in his eating habits and he had very pale poo.

Ipsen’s financial results for the first half of 2025 will be published on 31 July 2025 at 07:00 CET.

At just nine years old, Suzanne is a bright, creative young girl who loves dancing, drawing, exploring the woods, and watching birds. Despite living with Alagille syndrome (ALGS), a rare genetic condition, she embraces life with enthusiasm and curiosity.